Epitomee Medical Ltd (TLV: EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA
889.90
-29.30 (-3.19%)
Jan 21, 2025, 5:24 PM IDT
Epitomee Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 13.12 | 15.63 | 35.95 | 64.31 | 4.83 |
Short-Term Investments | 11.81 | 19.16 | 10.18 | - | 15.58 |
Cash & Short-Term Investments | 24.93 | 34.79 | 46.13 | 64.31 | 20.41 |
Cash Growth | - | -24.59% | -28.27% | 215.12% | - |
Other Receivables | 0.3 | 0.17 | 0.18 | 0.39 | 0.06 |
Receivables | 0.3 | 0.17 | 0.18 | 0.39 | 0.06 |
Prepaid Expenses | - | 0.03 | 0.06 | 0.1 | 0.16 |
Other Current Assets | 0.23 | 0.07 | 0.13 | 0.04 | 0.06 |
Total Current Assets | 25.47 | 35.06 | 46.51 | 64.83 | 20.69 |
Property, Plant & Equipment | 16.06 | 4.93 | 8.42 | 1.13 | 0.62 |
Other Long-Term Assets | 0.28 | 0.27 | 0.28 | 0.06 | 0.01 |
Total Assets | 41.81 | 40.27 | 55.2 | 66.02 | 21.32 |
Accounts Payable | 0.62 | 0.54 | 0.31 | 1.14 | 0.13 |
Accrued Expenses | - | 0.96 | 1.37 | 0.99 | 0.46 |
Current Portion of Leases | 0.58 | 0.45 | 0.49 | 0.3 | 0.18 |
Other Current Liabilities | 0.71 | 0 | 0 | 0.02 | - |
Total Current Liabilities | 1.9 | 1.96 | 2.16 | 2.45 | 0.77 |
Long-Term Debt | - | - | - | - | 6.35 |
Long-Term Leases | 3.78 | 3.51 | 3.6 | 0.28 | 0.23 |
Long-Term Unearned Revenue | - | - | 10 | 10 | 10 |
Total Liabilities | 5.68 | 5.47 | 15.76 | 12.73 | 17.35 |
Common Stock | 0.82 | 0.81 | 0.81 | 0.81 | 0.01 |
Additional Paid-In Capital | 93.66 | 93.17 | 92.14 | 90.6 | 30.01 |
Retained Earnings | -58.73 | -59.56 | -53.87 | -38.48 | -26.97 |
Comprehensive Income & Other | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Total Common Equity | 36.13 | 34.8 | 39.45 | 53.3 | 3.43 |
Shareholders' Equity | 36.13 | 34.8 | 39.45 | 53.3 | 3.98 |
Total Liabilities & Equity | 41.81 | 40.27 | 55.2 | 66.02 | 21.32 |
Total Debt | 4.36 | 3.96 | 4.08 | 0.58 | 6.76 |
Net Cash (Debt) | 20.58 | 30.83 | 42.05 | 63.73 | 13.65 |
Net Cash Growth | - | -26.67% | -34.03% | 366.78% | - |
Net Cash Per Share | 0.66 | 1.04 | 1.43 | 36.24 | 59.75 |
Filing Date Shares Outstanding | 29.76 | 29.52 | 29.46 | 29.23 | 0.23 |
Total Common Shares Outstanding | 29.76 | 29.52 | 29.46 | 29.23 | 0.23 |
Working Capital | 23.57 | 33.1 | 44.34 | 62.38 | 19.92 |
Book Value Per Share | 1.21 | 1.18 | 1.34 | 1.82 | 15.00 |
Tangible Book Value | 36.13 | 34.8 | 39.45 | 53.3 | 3.43 |
Tangible Book Value Per Share | 1.21 | 1.18 | 1.34 | 1.82 | 15.00 |
Machinery | - | 1.07 | 3.89 | 1.23 | 0.83 |
Leasehold Improvements | - | 0.17 | 1.18 | 0.16 | 0.16 |
Source: S&P Capital IQ. Standard template. Financial Sources.